Carl A. Merton Buys 26,000 Shares of Tilray Inc (NASDAQ:TLRY) Stock

Tilray Inc (NASDAQ:TLRY) CFO Carl A. Merton purchased 26,000 shares of the business’s stock in a transaction on Friday, November 15th. The shares were acquired at an average price of $1.36 per share, for a total transaction of $35,360.00. Following the completion of the acquisition, the chief financial officer now directly owns 26,000 shares in the company, valued at approximately $35,360. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Tilray Stock Down 0.8 %

Shares of NASDAQ:TLRY opened at $1.31 on Wednesday. The business’s 50 day moving average is $1.64 and its 200 day moving average is $1.76. Tilray Inc has a 12-month low of $1.28 and a 12-month high of $2.97. The stock has a market cap of $1.18 billion, a price-to-earnings ratio of -4.85 and a beta of 2.14. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.04). The firm had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business’s revenue for the quarter was up 13.0% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.10) EPS. On average, sell-side analysts forecast that Tilray Inc will post -0.14 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tilray

A number of institutional investors have recently added to or reduced their stakes in TLRY. Swiss National Bank boosted its stake in shares of Tilray by 3.6% in the 1st quarter. Swiss National Bank now owns 1,490,938 shares of the company’s stock worth $3,683,000 after buying an additional 51,700 shares during the last quarter. Avantax Advisory Services Inc. increased its position in shares of Tilray by 46.2% during the 1st quarter. Avantax Advisory Services Inc. now owns 53,110 shares of the company’s stock valued at $131,000 after purchasing an additional 16,792 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Tilray by 3.5% during the 1st quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company’s stock worth $8,707,000 after purchasing an additional 117,891 shares during the period. CreativeOne Wealth LLC purchased a new position in shares of Tilray in the 1st quarter worth about $165,000. Finally, Lazard Asset Management LLC bought a new position in Tilray during the first quarter valued at about $118,000. 9.35% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, Roth Mkm reduced their target price on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.